Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis-Reference-Cited by-同舟云学术

Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis

Published:2017 Issue:2 Volume:95 Page:156-161
ISSN:0012-2823
Container-title:Digestion
language:en
Short-container-title:Digestion

Author:

Hoshino Shintaro,Kawami Noriyuki^ORCID,Takenouchi Nana,Umezawa Mariko,Hanada Yuriko,Hoshikawa Yoshimasa,Kawagoe Tetsuro,Sano Hirohito,Hoshihara Yoshio,Nomura Tsutomu,Iwakiri Katsuhiko

Publisher

S. Karger AG

Subject

Gastroenterology

Reference17 articles.

1. Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism

2. Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan

3. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

4. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?;Expert Opinion on Investigational Drugs;2024-08-30

2. A scientometrics analysis and visualization of refractory gastroesophageal reflux disease;Frontiers in Pharmacology;2024-07-30

3. Treatment Response With Potassium-competitive Acid Blockers Based on Clinical Phenotypes of Gastroesophageal Reflux Disease: A Systematic Literature Review and Meta-analysis;Journal of Neurogastroenterology and Motility;2024-07-30

4. Evaluating vonoprazan and tegoprazan for gastroesophageal reflux disease treatment in Chinese Healthcare: an EVIDEM framework analysis;BMC Gastroenterology;2024-06-20

5. Vonoprazan causes symptomatic improvement in non-erosive gastroesophageal reflux disease: A systematic review and meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2024-06